Basics |
Company: |
Lineage Cell Therapeutics, Inc. |
IPO Date: |
April 1, 1992 |
Sector: |
Healthcare |
Industry: |
Biotech |
Market Cap: |
$154.34M |
Activated in VL: |
True |
Average Daily Range |
Avg Daily Range: |
$0.05 | 3.69%
|
Avg Daily Range (30 D): |
$0.03 | 4.35%
|
Avg Daily Range (90 D): |
$0.03 | 4.19%
|
Institutional Daily Volume |
Avg Daily Volume: |
.77M |
Avg Daily Volume (30 D): |
1.03M |
Avg Daily Volume (90 D): |
1.52M |
Trade Size |
Avg Trade Size (Sh.): |
275 |
Avg Trade Size (Sh.) (30 D): |
370 |
Avg Trade Size (Sh.) (90 D): |
470 |
Institutional Trades |
Total Inst.Trades: |
40 |
Avg Inst. Trade: |
$3.55M |
Avg Inst. Trade (30 D): |
$3.83M |
Avg Inst. Trade (90 D): |
$1.65M |
Avg Inst. Trade Volume: |
2.59M |
Avg Inst. Trades (Per Day): |
1 |
Market Closing Trades |
Avg Closing Trade: |
$7.12M |
Avg Closing Trade (30 D): |
$1.87M |
Avg Closing Trade (90 D): |
$1.87M |
Avg Closing Volume: |
4.15M |
|
|
|
|
Financials |
|
TTM |
Q3 2024 |
Q2 2024 |
Basic EPS
|
$-.11
|
$-.02
|
$-.03
|
Diluted EPS
|
$-.11
|
$-.02
|
$-.03
|
Revenue
|
$ 8.72M
|
$ 3.78M
|
$ 1.41M
|
Gross Profit
|
$ 8.28M
|
$ 3.74M
|
$ 1.36M
|
Net Income / Loss
|
$ -20.11M
|
$ -3M
|
$ -5.77M
|
Operating Income / Loss
|
$ -22.73M
|
$ -3.84M
|
$ -5.87M
|
Cost of Revenue
|
$ .44M
|
$ .04M
|
$ .04M
|
Net Cash Flow
|
$ -3.69M
|
$ -1.86M
|
$ -13.95M
|
PE Ratio
|
|
|
|
|